SYDNEY and NEW YORK, Nov. 14, 2023 /PRNewswire/ -- ObvioHealth, a virtual research organization (VRO) delivering stronger clinical evidence through tech-enabled trials, and Chemist Warehouse, Australia's largest chain of retail pharmacies, announced a partnership today to bring more efficient and convenient clinical trials to Australia.
Global virtual research organisation (VRO) ObvioHealth has launched its new suite of patient-centric tools for delivering stronger clinical trial evidence.
ObvioHealth has introduced a next-generation decentralised clinical trial (DCT) platform and mobile application called ‘ObvioGo’ to provide robust therapeutic efficacy and safety evidence.
ObvioHealth has signed a new global licensing agreement with healthcare and diagnostic software solutions provider Dedalus Group to obtain access to the latter’s data mining technology
ObvioHealth has developed artificial intelligence (AI) based technologies designed to take the subjectivity out of data collection and assessment in clinical trials involving children. The technologies, called the pediatric GI instrument and the pediatric cry capture instrument, are designed to make data capture easier for caregivers and children while facilitating the scoring of unstructured data by expert assessors.
?ObvioHealth has developed two new digital tools to enhance precision and lower the burden on patients/caregivers in paediatric clinical trials.
NEW YORK, Sept. 30, 2021 /PRNewswire/ -- ObvioHealth, a global Virtual Research Organization (VRO), today announces the launch of a first-of-its kind clinical trial in Australia, using a combination of in-home data collection methods that will reduce, and in some cases, eliminate the need for follow-up visits to clinics.
Castor joins the ranks of Medable, Science 37, Curebase and ObvioHealth with $45 million in funding for research and decentralized clinical trials.
Obviously, virtual clinical trials are hot: ObvioHealth secured $31 million to expand in Europe and the Asia-Pacific region with partners.